Winston Kung
Net worth: 90 917 $ as of 2026-04-29
Net worth: 90 917 $ as of 2026-04-29
Mr. Winston W.
Kung is an Independent Director at Corbus Pharmaceuticals Holdings, Inc., a Chief Financial Officer & Treasurer at Arrivent BioPharma, Inc. and an Independent Director at Janux Therapeutics, Inc. He is on the Board of Directors at Corbus Pharmaceuticals Holdings, Inc. and Janux Therapeutics, Inc. Mr. Kung was previously employed as a Chief Operating & Financial Officer by PMV Pharmaceuticals, Inc., a Chief Business Officer by Celgene Cellular Therapeutics, a VP-Business Development & Global Alliances by Celgene Corp., a Director-Global Healthcare by Citigroup, Inc., a Vice President-Global Mergers & Acquisitions by Lehman Brothers, Inc., a Principal by Amgen, Inc., and a Co-Founder by Alliance Management Group.
He also served on the board at Alliqua BioMedical, Inc. and Aitia, Inc. He received his undergraduate degree from Brown University and an MBA from Harvard Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-22 | 5,566 ( 0.03% ) | 54 992 $ | 2026-04-29 | |
| 2025-06-10 | 2,500 ( 0% ) | 35 925 $ | 2026-04-29 | |
| 2026-02-01 | 0 ( -.--% ) | - $ | 2026-04-29 |
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director/Board Member | 2022-09-21 |
| ARRIVENT BIOPHARMA, INC. | Director of Finance/CFO | 2023-12-31 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2024-08-15 |
| Companies | Position | End |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director of Finance/CFO | 2024-01-03 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Operates as a biomedical company | Director/Board Member | 2017-11-23 |
| CELGENE | Corporate Officer/Principal | 2017-10-31 |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Corporate Officer/Principal | 2015-01-31 |
| CITIGROUP INC. | Corporate Officer/Principal | 2013-03-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 14 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Operates as a biomedical company | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Alliance Management Group
Alliance Management Group Real Estate DevelopmentFinance Provides property management | Finance |
Select your edition
All financial news and data tailored to specific country editions